[VT | September 3, 2026 | Philadelphia PA] The U.S. Department of the Treasury and the Internal Revenue Service published proposed regulations on September 4 […]
Federal Agencies
Protected: Genesis Mission Summit 2026: 342 Participating Institutions
There is no excerpt because this is a protected post.
Genesis Mission Summit 2026: Congress
[VT | July 22, 2026 | Washington D.C.] Darío Gil, U.S. Department of Energy (DOE) Under Secretary for Science and lead of the Genesis Mission, […]
Genesis Mission Summit 2026: Internet of Science
[VT | July 22, 2026 | Washington D.C.] Darío Gil, Under Secretary for Science at the U.S. Department of Energy (DOE) and head of the […]
Genesis Mission Summit 2026: AI for Science
[VT | July 22, 2026 | Washington D.C.] From protein structure prediction to mathematical proofs, X-ray imaging, electric-grid simulation, and the design and manufacturing of […]
Genesis Mission Summit 2026: 278 Projects Behind the U.S. AI for Science Strategy
[VT | July 22, 2026 | Washington D.C.] The inaugural Genesis Mission Annual Summit brought together White House and federal science officials, national laboratory leaders, […]
U.S. and Japan Launch $1 Billion Genesis Mission Partnership, Marking a New Era of AI-Driven Scientific Infrastructure
[VT | June 4, 2026 | Washington D.C.] Not Just an AI Announcement — A New Scientific Alliance The United States and Japan announced a […]
U.S. Department of Energy Awards $94 Million for Small Modular Reactor Projects and Nuclear Supply Chain Development
[VT | May 15, 2026 | Washington, D.C.] DOE funding supports reactor site permitting, fuel fabrication, heavy manufacturing equipment, and domestic nuclear component production across […]
State Department Issues Lunar New Year Message
[VT | February 16, | Washington D.C.] U.S. Secretary of State Marco Rubio issued a Lunar New Year message on Sunday, extending greetings to those […]
FDA Launches BsUFA Reauthorization: Billions in Funding to Accelerate Biosimilar Approval and Market Access
[VT I Maryland, December 3, 2025 ] The U.S. Food and Drug Administration (FDA) held a public meeting on December 3 to initiate the reauthorization process […]